LEVO-DROMORAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levo-dromoran, and when can generic versions of Levo-dromoran launch?
Levo-dromoran is a drug marketed by Valeant Pharm Intl and is included in two NDAs.
The generic ingredient in LEVO-DROMORAN is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levo-dromoran
A generic version of LEVO-DROMORAN was approved as levorphanol tartrate by HIKMA on March 31st, 2000.
Summary for LEVO-DROMORAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LEVO-DROMORAN at DailyMed |
US Patents and Regulatory Information for LEVO-DROMORAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | LEVO-DROMORAN | levorphanol tartrate | INJECTABLE;INJECTION | 008719-001 | Dec 19, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharm Intl | LEVO-DROMORAN | levorphanol tartrate | TABLET;ORAL | 008720-001 | Dec 19, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |